Fusion Pharmaceuticals Inc. Operating Lease Cost
Fusion Pharmaceuticals Inc. reported Operating Lease Cost of $1.21 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. operating lease, cost for the quarter ending 2024-03-31 was $1.21M, a 142.94% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, cost for the quarter ending 2023-12-31 was $1.21M, a 232.14% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, cost for the quarter ending 2023-09-30 was $985.00K, a 167.66% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, cost for the quarter ending 2023-06-30 was $994.00K, a 169.38% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, cost for fiscal 2023 was $3.68M, a 151.12% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. operating lease, cost for fiscal 2022 was $1.47M, a 5.31% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. operating lease, cost for fiscal 2021 was $1.39M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.21M 10-Q · filed 2024-05-07 | $2.41M derived: sum of 2 quarters · filed 2024-05-07 | $3.40M derived: sum of 3 quarters · filed 2024-05-07 | $4.39M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $2.19M derived: sum of 2 quarters · filed 2024-03-20 | $3.19M derived: sum of 3 quarters · filed 2024-03-20 | $3.68M 10-K · filed 2024-03-20 |
| 2023-09-30 | $985.00K 10-Q · filed 2023-11-07 | $1.98M derived: sum of 2 quarters · filed 2023-11-07 | $2.48M 10-Q · filed 2023-11-07 | $2.84M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $994.00K 10-Q · filed 2023-08-08 | $1.49M 10-Q · filed 2023-08-08 | $1.85M derived: sum of 3 quarters · filed 2024-05-07 | $2.22M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $496.00K 10-Q · filed 2024-05-07 | $860.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.23M derived: sum of 3 quarters · filed 2024-05-07 | $1.60M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $732.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.10M derived: sum of 3 quarters · filed 2024-03-20 | $1.47M 10-K · filed 2024-03-20 |
| 2022-09-30 | $368.00K 10-Q · filed 2023-11-07 | $737.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.10M 10-Q · filed 2023-11-07 | $1.46M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $369.00K 10-Q · filed 2023-08-08 | $735.00K 10-Q · filed 2023-08-08 | $1.10M derived: sum of 3 quarters · filed 2023-08-08 | $1.46M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $366.00K 10-Q · filed 2023-05-11 | $727.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.09M derived: sum of 3 quarters · filed 2023-05-11 | $1.46M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $726.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.09M derived: sum of 3 quarters · filed 2023-03-16 | $1.39M 10-K · filed 2023-03-16 |
| 2021-09-30 | $365.00K 10-Q · filed 2022-11-08 | $732.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.03M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $367.00K 10-Q · filed 2022-08-09 | $667.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-10 |